In ERBB2 (oncogenic gene, also known as her2/Neu)-positive breast cancer, the RAS-MAPK kinase pathway is one of the signaling cascades activated by ERBB2 and synergizes with the PI3K/AKT pathway. This evidence concerns the gene ERBB2 and breast cancer.